A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept®
Status:
Completed
Trial end date:
2018-03-14
Target enrollment:
Participant gender:
Summary
A study to assess the steady-state bioequivalence of once-weekly Corplex™ Donepezil 10 mg
Transdermal Delivery System (TDS) compared to daily administration of Aricept®